Mann N S, Tsai M F, Nair P K
Gastroenterology-Hepatology-Nutrition Section, Olin E. Teague Veterans' Center, Texas A&M University, College of Medicine, Temple.
Am J Gastroenterol. 1989 Dec;84(12):1494-6.
We evaluated the frequency with which Barrett's esophagus (BE) occurs in patients with symptomatic reflux esophagitis, and compared the clinical endoscopic and manometric features of patients with Barrett's esophagus with those of patients who had non-Barrett's esophagitis (NBE). The effect of 6 months' medical treatment on BE patients was reevaluated by repeating manometry, endoscopy, and biopsy. Esophageal manometry was performed by perfusion technique and endoscopic biopsies were obtained. There were 180 patients; 20 (11%) were found to have BE. The vast majority of BE patients were caucasians. BE patients had symptoms of gastroesophageal reflux for a longer time than did NBE patients. Mean lower esophageal sphincter pressure in BE patients was lower than that in NBE patients. On medical treatment, the severity of esophagitis as judged by endoscopic criteria in BE patients was reduced, but there was no increase in lower esophageal sphincter pressure and no regression of the columnar epithelium.
我们评估了有症状的反流性食管炎患者中巴雷特食管(BE)的发生频率,并比较了巴雷特食管患者与非巴雷特食管(NBE)患者的临床、内镜及测压特征。通过重复测压、内镜检查和活检,重新评估了药物治疗6个月对BE患者的影响。采用灌注技术进行食管测压并获取内镜活检标本。共有180例患者,其中20例(11%)被发现患有BE。绝大多数BE患者为白种人。BE患者出现胃食管反流症状的时间比NBE患者更长。BE患者的食管下括约肌平均压力低于NBE患者。在药物治疗方面,根据内镜标准判断,BE患者食管炎的严重程度有所减轻,但食管下括约肌压力未升高,柱状上皮也未消退。